퀴놀론 시장 보고서(2026년)

Quinolones are a class of bactericidal antibiotics that work by directly killing bacterial cells, targeting both gram-positive and gram-negative bacteria. They are commonly used to treat a variety of infectious diseases caused by bacterial pathogens.

The main types of quinolones include norfloxacin, ofloxacin, ciprofloxacin, gemifloxacin, and others. Norfloxacin is a fluoroquinolone antibiotic used to treat bacterial infections such as conjunctivitis and urinary tract infections. It targets both gram-positive and gram-negative pathogens. Quinolones like norfloxacin are distributed through various channels, including hospital pharmacies, retail pharmacies, and online pharmacies.

Tariffs have impacted the quinolones market by increasing the cost of imported raw materials and active pharmaceutical ingredients, leading to higher production expenses and supply chain disruptions. The hospital pharmacy and retail pharmacy segments in regions like North America and Europe are most affected. Some manufacturers may benefit by sourcing locally or investing in domestic production, creating opportunities for cost optimization and market resilience.

The quinolones market research report is one of a series of new reports from The Business Research Company that provides quinolones market statistics, including quinolones industry global market size, regional shares, competitors with a quinolones market share, detailed quinolones market segments, market trends and opportunities, and any further data you may need to thrive in the quinolones industry. This quinolones market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The quinolones market size has grown steadily in recent years. It will grow from $51.89 billion in 2025 to $54.48 billion in 2026 at a compound annual growth rate (CAGR) of 5.0%. The growth in the historic period can be attributed to increasing prevalence of bacterial infections, rise in hospital admissions, high demand for broad-spectrum antibiotics, growth of retail pharmacies, government initiatives for infectious disease control.

The quinolones market size is expected to see strong growth in the next few years. It will grow to $66.44 billion in 2030 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to advancements in precision medicine, development of novel quinolone formulations, expansion of online pharmacy channels, increasing awareness about antimicrobial stewardship, rising adoption of digital health monitoring tools. Major trends in the forecast period include rising antibiotic resistance management, expansion of generic drug availability, personalized treatment approaches, growth in outpatient and home healthcare services, increased investment in r&d for novel quinolones.

The rising threat of antimicrobial resistance (AMR) is expected to drive the growth of the quinolones market. AMR refers to the ability of microorganisms, such as bacteria, viruses, fungi, and parasites, to resist the effects of antimicrobial drugs. Quinolones, with their broad spectrum of activity, are effective against a wide range of bacteria and are often prescribed when other treatment options are limited. They are able to penetrate various tissues, making them a preferred choice in specific cases of infection. For example, in October 2025, the World Health Organization (WHO) reported a global analysis using data from over 23 million confirmed cases of infections, highlighting the rising prevalence of antibiotic resistance. This trend is expected to fuel the demand for quinolones.

To capitalize on this growing market, major companies are focusing on developing innovative products, such as fluoroquinolone antibiotic eye drops. These eye drops are used to treat bacterial infections of the eye. For instance, in July 2023, Harrow Health Inc., a U.S.-based pharmaceutical company, launched Vigamox, a fluoroquinolone ophthalmic solution containing moxifloxacin hydrochloride. This product is recommended for preventing eye infections both before and after surgery.

In June 2023, Bausch + Lomb Incorporated, a U.S.-based eye health company, acquired Novartis International AG for an undisclosed amount. The acquisition is part of Bausch & Lomb's strategy to restructure its pharmaceutical division and strengthen its position in the ocular surface disorder market.

Major companies operating in the quinolones market are Bayer AG, Novartis AG, Sanofi SA, Merck & Co. Inc., LG Life Sciences, Pfizer Inc., Viatris Inc., Lupin Limited, Hikma Pharmaceuticals plc, Zydus Group, KYORIN Holdings Inc., Teva Pharmaceutical Industries Ltd., GSK plc, Zee Laboratories, Cipla Ltd., Geo Pharma Pvt. Ltd., Finecure Pharmaceuticals, AstraZeneca plc, Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Cadila Healthcare Ltd., Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Macleods Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Hetero Drugs Ltd., Wockhardt Ltd.

North America was the largest region in the quinolones market in 2025. The regions covered in the quinolones market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the quinolones market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The quinolones market consists of sales of bedaquiline. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Quinolones Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses quinolones market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for quinolones ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The quinolones market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Norfloxacin; Ofloxacin; Ciprofloxacin; Gemifloxacin; Other Types
• 2) By Pathogen Type: Gram-Positive Pathogen; Gram-Negative Pathogen
• 3) By Application: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• Companies Mentioned: Bayer AG; Novartis AG; Sanofi SA; Merck & Co. Inc.; LG Life Sciences; Pfizer Inc.; Viatris Inc.; Lupin Limited; Hikma Pharmaceuticals plc; Zydus Group; KYORIN Holdings Inc.; Teva Pharmaceutical Industries Ltd.; GSK plc; Zee Laboratories; Cipla Ltd.; Geo Pharma Pvt. Ltd.; Finecure Pharmaceuticals; AstraZeneca plc; Sun Pharmaceutical Industries Ltd.; Dr. Reddy's Laboratories Ltd.; Cadila Healthcare Ltd.; Glenmark Pharmaceuticals Ltd.; Alkem Laboratories Ltd.; Torrent Pharmaceuticals Ltd.; Macleods Pharmaceuticals Ltd.; Alembic Pharmaceuticals Ltd.; Hetero Drugs Ltd.; Wockhardt Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Quinolones Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Quinolones Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Quinolones Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Quinolones Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Industry 4.0 & Intelligent Manufacturing
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Artificial Intelligence & Autonomous Intelligence
  • 4.1.5 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Rising Antibiotic Resistance Management
  • 4.2.2 Expansion of Generic Drug Availability
  • 4.2.3 Personalized Treatment Approaches
  • 4.2.4 Growth in Outpatient and Home Healthcare Services
  • 4.2.5 Increased Investment in R&D for Novel Quinolones

5. Quinolones Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Clinics
• 5.3 Retail Pharmacies
• 5.4 Online Pharmacies
• 5.5 Healthcare Institutions

6. Quinolones Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Quinolones Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Quinolones PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Quinolones Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Quinolones Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Quinolones Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Quinolones Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Quinolones Market Segmentation

• 9.1. Global Quinolones Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Norfloxacin, Ofloxacin, Ciprofloxacin, Gemifloxacin, Other Types
• 9.2. Global Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Gram-Positive Pathogen, Gram-Negative Pathogen
• 9.3. Global Quinolones Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

10. Quinolones Market Regional And Country Analysis

• 10.1. Global Quinolones Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Quinolones Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Quinolones Market

• 11.1. Asia-Pacific Quinolones Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Quinolones Market, Segmentation By Type, Segmentation By Pathogen Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Quinolones Market

• 12.1. China Quinolones Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Quinolones Market, Segmentation By Type, Segmentation By Pathogen Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Quinolones Market

• 13.1. India Quinolones Market, Segmentation By Type, Segmentation By Pathogen Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Quinolones Market

• 14.1. Japan Quinolones Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Quinolones Market, Segmentation By Type, Segmentation By Pathogen Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Quinolones Market

• 15.1. Australia Quinolones Market, Segmentation By Type, Segmentation By Pathogen Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Quinolones Market

• 16.1. Indonesia Quinolones Market, Segmentation By Type, Segmentation By Pathogen Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Quinolones Market

• 17.1. South Korea Quinolones Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Quinolones Market, Segmentation By Type, Segmentation By Pathogen Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Quinolones Market

• 18.1. Taiwan Quinolones Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Quinolones Market, Segmentation By Type, Segmentation By Pathogen Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Quinolones Market

• 19.1. South East Asia Quinolones Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Quinolones Market, Segmentation By Type, Segmentation By Pathogen Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Quinolones Market

• 20.1. Western Europe Quinolones Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Quinolones Market, Segmentation By Type, Segmentation By Pathogen Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Quinolones Market

• 21.1. UK Quinolones Market, Segmentation By Type, Segmentation By Pathogen Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Quinolones Market

• 22.1. Germany Quinolones Market, Segmentation By Type, Segmentation By Pathogen Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Quinolones Market

• 23.1. France Quinolones Market, Segmentation By Type, Segmentation By Pathogen Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Quinolones Market

• 24.1. Italy Quinolones Market, Segmentation By Type, Segmentation By Pathogen Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Quinolones Market

• 25.1. Spain Quinolones Market, Segmentation By Type, Segmentation By Pathogen Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Quinolones Market

• 26.1. Eastern Europe Quinolones Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Quinolones Market, Segmentation By Type, Segmentation By Pathogen Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Quinolones Market

• 27.1. Russia Quinolones Market, Segmentation By Type, Segmentation By Pathogen Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Quinolones Market

• 28.1. North America Quinolones Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Quinolones Market, Segmentation By Type, Segmentation By Pathogen Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Quinolones Market

• 29.1. USA Quinolones Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Quinolones Market, Segmentation By Type, Segmentation By Pathogen Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Quinolones Market

• 30.1. Canada Quinolones Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Quinolones Market, Segmentation By Type, Segmentation By Pathogen Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Quinolones Market

• 31.1. South America Quinolones Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Quinolones Market, Segmentation By Type, Segmentation By Pathogen Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Quinolones Market

• 32.1. Brazil Quinolones Market, Segmentation By Type, Segmentation By Pathogen Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Quinolones Market

• 33.1. Middle East Quinolones Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Quinolones Market, Segmentation By Type, Segmentation By Pathogen Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Quinolones Market

• 34.1. Africa Quinolones Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Quinolones Market, Segmentation By Type, Segmentation By Pathogen Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Quinolones Market Regulatory and Investment Landscape

36. Quinolones Market Competitive Landscape And Company Profiles

• 36.1. Quinolones Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Quinolones Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Quinolones Market Company Profiles
  • 36.3.1. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. LG Life Sciences Overview, Products and Services, Strategy and Financial Analysis

37. Quinolones Market Other Major And Innovative Companies

• Pfizer Inc., Viatris Inc., Lupin Limited, Hikma Pharmaceuticals plc, Zydus Group, KYORIN Holdings Inc., Teva Pharmaceutical Industries Ltd., GSK plc, Zee Laboratories, Cipla Ltd., Geo Pharma Pvt. Ltd., Finecure Pharmaceuticals, AstraZeneca plc, Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd.

38. Global Quinolones Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Quinolones Market

40. Quinolones Market High Potential Countries, Segments and Strategies

• 40.1 Quinolones Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Quinolones Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Quinolones Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer